It gets personal

[jon-nyc]

Not a lot of details yet but the press release came from HHS, DoE, and GSA. I think GSA is just helping craft the individual cancellation letters. I tried to reread my link but GSA site is down for ‘maintenance’.

[jon-nyc]

Having said that, there are not a lot of details released yet.

[Renauda]

Hoping your noble medical research project is saved from the pyre.

The uncertainty you are under is so wasteful and unnecessary. A dictatorship of the inept executed by mindless bean counters

[taiwan_girl]

Hope things turn in the right direction for you @jon-nyc .

Killing a mosquito with a sledgehammer is not the right answer.

[jon-nyc]

Our PI has't gotten a stop work letter yet so it seems like a good sign. Some colleagues of hers have for CDC-associated work. Maybe NIH really was excluded. Though it's the 800lb gorilla of grant making institutions.

[Mik]

No significant cuts on our side yet, that I’m aware of anyway.

[jon-nyc]

We lost our funding last night.

[Jolly]

Other possible grants?

[Axtremus]

Try China?

[Mik]

How were you funded and what percentage? Was it one grant or more?

[Axtremus]

GoFundMe?

[Axtremus]

Is stem cell involved?
If not, maybe the churches can step in.

[jon-nyc]

It was a single U Grant originally for $6MM. I'm not exactly sure how much has been billed against it, my guess is roughly half.

We're looking into the possibility that one or two other center might be able to invoice the NIH directly for their participation based on the way the grant is worded, which would help. We will also fundraise against it both from interested biotechs and patients. We will also have patients send letters, especially patients in Alabama, North Carolina, South Carolina, and Utah which all have GOP senators and affected centers.

Senator Thom Tillis may not see the logic in cutting rare disease funding at UNC because Hamilton Hall was occupied last year. Ditto Mike Lee and UU.

[xenon]

@jon-nyc said in It gets personal:

We lost our funding last night.

That’s a bummer. Hopefully the work can continue.

[Mik]

I’m working with both UNC and U of Utah now, plus Wake Forest.

[blondie]

I’m sorry @jon-nyc . You and your colleagues are smart though. I’m confident you’ll find a solution.

[jon-nyc]

The work won't end, it's too important, we won't let it.

The bigger fear is what happens with research and clinical trials generally if the indirects get cut overnight. That's too much for a little foundation to backstop.

[Mik]

I can see cutting future grants. Cutting active studies, especially clinical trials, is exceptionally wasteful.

[Axtremus]

@Mik said in It gets personal:

Cutting active studies, especially clinical trials, is exceptionally wasteful.

This is more appreciated in the biomed fields but less appreciated in the computer/infotech fields.

[taiwan_girl]

Sorry for the thread hijack, but another area where the funding cuts are somewhat personal. A (distant) friend works in the Soybean Innovation Lab at the University of IL. They have lost their funding and are in the process of closing.

Illinois is the leading producer of soybeans in the United States, and the industry is crucial to Illinois’ economy. According to the Illinois Department of Agriculture, Illinois is the nation’s second-leading exporter of soybeans and ranks third in the export of agricultural goods as a whole, earning over $8 billion worth.

https://soybeaninnovationlab.illinois.edu